Azerbaijan vs Mongolia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Azerbaijan
0.3%
in 2024
Mongolia
0.3%
in 2024
Azerbaijan rank
86th
Mongolia rank
86th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Azerbaijan
- Mongolia
How they compare
Azerbaijan currently reports 0.3% against 0.3% in Mongolia, a difference of 0.0%.
Across all 10 years both countries report, Mongolia has been ahead every year.
Azerbaijan ranks 86th and Mongolia ranks 86th of 247 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.4% | 0.2% | Mongolia |
| 2020s | 0.3% | 0.3% | 0.1% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Azerbaijan or Mongolia?
- Azerbaijan, at 0.3% against 0.3% in Mongolia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Azerbaijan and Mongolia?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Mongolia?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Mongolia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Azerbaijan ranks 86th and Mongolia ranks 86th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.